TABLE OF CONTENTS
Volume 32, Issue 1 (January 2007)
Original Articles
Preclinical Research
SSR180711, a Novel Selective 
7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile FREE
Bruno Biton, Olivier E Bergis, Frédéric Galli, Alain Nedelec, Alistair W Lochead, Samir Jegham, Danielle Godet, Christophe Lanneau, Raphaël Santamaria, Françoise Chesney, Jacques Léonardon, Patrick Granger, Marc W Debono, Georg A Bohme, Frédéric Sgard, François Besnard, David Graham, Annick Coste, André Oblin, Olivier Curet, Xavier Vigé, Corinne Voltz, Liliane Rouquier, Josiane Souilhac, Vincent Santucci, Christiane Gueudet, Dominique Françon, Régis Steinberg, Guy Griebel, Florence Oury-Donat, Pascal George, Patrick Avenet and Bernard Scatton
Neuropsychopharmacology 32: 1-16; advance online publication, October 4, 2006; doi:10.1038/sj.npp.1301189
SSR180711, a Novel Selective 7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia FREE
Philippe Pichat, Olivier E Bergis, Jean-Paul Terranova, Alexandre Urani, Christine Duarte, Vincent Santucci, Christiane Gueudet, Carole Voltz, Régis Steinberg, Jeanne Stemmelin, Florence Oury-Donat, Patrick Avenet, Guy Griebel and Bernard Scatton
Neuropsychopharmacology 32: 17-34; advance online publication, August 23, 2006; doi:10.1038/sj.npp.1301188
Heteromeric Nicotinic Acetylcholine–Dopamine Autoreceptor Complexes Modulate Striatal Dopamine Release FREE
Davide Quarta, Francisco Ciruela, Kshitij Patkar, Janusz Borycz, Marcello Solinas, Carme Lluis, Rafael Franco, Roy A Wise, Steven R Goldberg, Bruce T Hope, Amina S Woods and Sergi Ferré
Neuropsychopharmacology 32: 35-42; advance online publication, May 17, 2006; doi:10.1038/sj.npp.1301103
Galantamine Enhances Dopaminergic Neurotransmission In Vivo Via Allosteric Potentiation of Nicotinic Acetylcholine Receptors FREE
Björn Schilström, Vladimir B Ivanov, Charlotte Wiker and Torgny H Svensson
Neuropsychopharmacology 32: 43-53; advance online publication, April 26, 2006; doi:10.1038/sj.npp.1301087
Linking Animal Models of Psychosis to Computational Models of Dopamine Function FREE
Andrew J Smith, Ming Li, Suzanna Becker and Shitij Kapur
Neuropsychopharmacology 32: 54-66; advance online publication, May 10, 2006; doi:10.1038/sj.npp.1301086
Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways FREE
Jonathan D Urban, Gabriel A Vargas, Mark von Zastrow and Richard B Mailman
Neuropsychopharmacology 32: 67-77; advance online publication, March 22, 2006; doi:10.1038/sj.npp.1301071
SLV313 (1-(2,3-Dihydro-Benzo[1,4]Dioxin-5-yl)-4- [5-(4-Fluoro-Phenyl)-Pyridin-3-ylmethyl]-Piperazine Monohydrochloride): A Novel Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist Potential Antipsychotic Drug FREE
Andrew C McCreary, Jeffrey C Glennon, Charles R Ashby Jr, Herbert Y Meltzer, Zhu Li, Jan-Hendrik Reinders, Mayke B Hesselink, Stephen K Long, Arnoud H Herremans, Herman van Stuivenberg, Rolf W Feenstra and Chris G Kruse
Neuropsychopharmacology 32: 78-94; advance online publication, May 17, 2006; doi:10.1038/sj.npp.1301098
Caspase-3 Activation in Rat Frontal Cortex Following Treatment with Typical and Atypical Antipsychotics FREE
L Fredrik Jarskog, John H Gilmore, Leisa A Glantz, Karissa L Gable, Thomas T German, Ruth I Tong and Jeffrey A Lieberman
Neuropsychopharmacology 32: 95-102; advance online publication, April 12, 2006; doi:10.1038/sj.npp.1301074
Upregulation of Ionotropic Glutamate Receptor Subunits within Specific Mesocorticolimbic Regions during Chronic Nicotine Self-Administration FREE
Fan Wang, Hao Chen, Jeffery D Steketee and Burt M Sharp
Neuropsychopharmacology 32: 103-109; advance online publication, February 1, 2006; doi:10.1038/sj.npp.1301033
Regulation by Nicotine of Gpr51 and Ntrk2 Expression in Various Rat Brain Regions FREE
Dongxiao Sun, Weihua Huang, Yoon Y Hwang, Yuan Zhang, Qin Zhang and Ming D Li
Neuropsychopharmacology 32: 110-116; advance online publication, June 21, 2006; doi:10.1038/sj.npp.1301134
Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference FREE
Anita C Hansson, Francisco J Bermúdez-Silva, Hanna Malinen, Petri Hyytiä, Irene Sanchez-Vera, Roberto Rimondini, Fernando Rodriguez de Fonseca, George Kunos, Wolfgang H Sommer and Markus Heilig
Neuropsychopharmacology 32: 117-126; advance online publication, February 8, 2006; doi:10.1038/sj.npp.1301034
Acute Functional Tolerance to Ethanol Mediated by Protein Kinase C
FREE
Melisa J Wallace, Philip M Newton, Miho Oyasu, Thomas McMahon, Wen-Hai Chou, Jacklyn Connolly and Robert O Messing
Neuropsychopharmacology 32: 127-136; advance online publication, March 15, 2006; doi:10.1038/sj.npp.1301059
Dopamine and Benzodiazepine-Dependent Mechanisms Regulate the EtOH-Enhanced Locomotor Stimulation in the GABAA 1 Subunit Null Mutant Mice FREE
Harry L June Sr, Katrina L Foster, William J A Eiler II, Joshua Goergen, Jason B Cook, Nathan Johnson, Boikai Mensah-Zoe, Jothan O Simmons, Harry L June Jr, Wenyuan Yin, James M Cook and Gregg E Homanics
Neuropsychopharmacology 32: 137-152; advance online publication, May 17, 2006; doi:10.1038/sj.npp.1301097
Clinical Research
Placebo-Controlled Trial Comparing Intermittent and Continuous Paroxetine in Premenstrual Dysphoric Disorder FREE
Mikael Landén, Hans Nissbrandt, Christer Allgulander, Karin Sörvik, Christina Ysander and Elias Eriksson
Neuropsychopharmacology 32: 153-161; advance online publication, October 11, 2006; doi:10.1038/sj.npp.1301216
Impact of Catechol-O-Methyltransferase on Prefrontal Brain Functioning in Schizophrenia Spectrum Disorders FREE
Ann-Christine Ehlis, Andreas Reif, Martin J Herrmann, Klaus-Peter Lesch and Andreas J Fallgatter
Neuropsychopharmacology 32: 162-170; advance online publication, June 28, 2006; doi:10.1038/sj.npp.1301151
Apolipoprotein E 4 Allele Increases Risk for Psychotic Symptoms in Alzheimer's Disease FREE
Kristina F Zdanys, Timothy G Kleiman, Martha G MacAvoy, Benjamin T Black, Tracy E Rightmer, Monique Grey, Katherine S Garman, Rajesh R Tampi, Joel Gelernter and Christopher H van Dyck
Neuropsychopharmacology 32: 171-179; advance online publication, July 12, 2006; doi:10.1038/sj.npp.1301148
L-DOPA Disrupts Activity in the Nucleus Accumbens during Reversal Learning in Parkinson's Disease FREE
Roshan Cools, Simon J G Lewis, Luke Clark, Roger A Barker and Trevor W Robbins
Neuropsychopharmacology 32: 180-189; advance online publication, July 12, 2006; doi:10.1038/sj.npp.1301153
The FEZ1 Gene Shows No Association to Schizophrenia in Caucasian or African American Populations FREE
Colin A Hodgkinson, David Goldman, Francesca Ducci, Pamela DeRosse, Daniel A Caycedo, Emily R Newman, John M Kane, Alec Roy and Anil K Malhotra
Neuropsychopharmacology 32: 190-196; advance online publication, August 16, 2006; doi:10.1038/sj.npp.1301177
Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients FREE
Rosa Maria Moresco, Lucia Pietra, Marta Henin, Andrea Panzacchi, Marco Locatelli, Lorena Bonaldi, Assunta Carpinelli, Clara Gobbo, Laura Bellodi, Daniela Perani and Ferruccio Fazio
Neuropsychopharmacology 32: 197-205; advance online publication, October 4, 2006; doi:10.1038/sj.npp.1301199
The Impact of Tryptophan Depletion and 5-HTTLPR Genotype on Passive Avoidance and Response Reversal Instrumental Learning Tasks FREE
Elizabeth C Finger, Abigail A Marsh, Beata Buzas, Niveen Kamel, Rebecca Rhodes, Meena Vythilingham, Daniel S Pine, David Goldman and James R Blair
Neuropsychopharmacology 32: 206-215; advance online publication, August 9, 2006; doi:10.1038/sj.npp.1301182
Effects of Acute Tryptophan Depletion on Mood and Facial Emotion Perception Related Brain Activation and Performance in Healthy Women with and without a Family History of Depression FREE
Frederik M van der Veen, Elisabeth A T Evers, Nicolaas E P Deutz and Jeroen A J Schmitt
Neuropsychopharmacology 32: 216-224; advance online publication, October 4, 2006; doi:10.1038/sj.npp.1301212
A Single Dose of the Selective Serotonin Reuptake Inhibitor Citalopram Exacerbates Anxiety in Humans: A Fear-Potentiated Startle Study FREE
Christian Grillon, Jessica Levenson and Daniel S Pine
Neuropsychopharmacology 32: 225-231; advance online publication, September 13, 2006; doi:10.1038/sj.npp.1301204
Blockade of the Mineralocorticoid Receptor in Healthy Men: Effects on Experimentally Induced Panic Symptoms, Stress Hormones, and Cognition FREE
Christian Otte, Steffen Moritz, Alexander Yassouridis, Maike Koop, Ana Maria Madrischewski, Klaus Wiedemann and Michael Kellner
Neuropsychopharmacology 32: 232-238; advance online publication, October 11, 2006; doi:10.1038/sj.npp.1301217
Intranasal Insulin Improves Memory in Humans: Superiority of Insulin Aspart FREE
Christian Benedict, Manfred Hallschmid, Katrin Schmitz, Bernd Schultes, Frank Ratter, Horst L Fehm, Jan Born and Werner Kern
Neuropsychopharmacology 32: 239-243; advance online publication, August 16, 2006; doi:10.1038/sj.npp.1301193
The Cognitive Effects of Electroconvulsive Therapy in Community Settings FREE
Harold A Sackeim, Joan Prudic, Rice Fuller, John Keilp, Philip W Lavori and Mark Olfson
Neuropsychopharmacology 32: 244-254; advance online publication, August 23, 2006; doi:10.1038/sj.npp.1301180
Obituary
Jon M Stolk, PhD, MD FREE
Carol A Tamminga
Neuropsychopharmacology 32: 255; doi:10.1038/sj.npp.1301236
Corrigendum
Increased Occupancy of Dopamine Receptors in Human Striatum during Cue-Elicited Cocaine Craving FREE
Dean F Wong, Hiroto Kuwabara, David J Schretlen, Katherine R Bonson, Yun Zhou, Ayon Nandi, James R Bra
i
, Alane S Kimes, Marika A Maris, Anil Kumar, Carlo Contoreggi, Jonathan Links, Monique Ernst, Olivier Rousset, Stephen Zukin, Anthony A Grace, Jae Sung Lee, Charles Rohde, Donald R Jasinski, Albert Gjedde and Edythe D London
Neuropsychopharmacology 32: 256; doi:10.1038/sj.npp.1301247
